Evidence map›Paper›PMID 30545136›Full record

ReviewMaterials (Basel, Switzerland)2018

Bioactive Glasses and Glass-Ceramics for Healthcare Applications in Bone Regeneration and Tissue Engineering.

Hugo R Fernandes, Anuraag Gaddam, Avito Rebelo, Daniela Brazete, George E Stan, José M F Ferreira

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Frontiers in bioengineering and biotechnology · 2025
    Article
  18. Review
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hugo R FernandesDepartment of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal. h.r.fernandes@ua.pt.
Anuraag GaddamDepartment of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal. anuraagg@ua.pt.ORCID 0000-0002-4266-6092
Avito RebeloDepartment of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal. avitorebelo@ua.pt.ORCID 0000-0003-0909-0375
Daniela BrazeteDepartment of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal. d.s.b@ua.pt.
George E StanNational Institute of Materials Physics, RO-077125 Magurele, Romania. george_stan@infim.ro.
José M F FerreiraDepartment of Materials and Ceramic Engineering, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal. jmf@ua.pt.ORCID 0000-0002-7520-2809

Funding

Ciência e a Tecnologia (FCT), Portugal SFRH/BPD/110883/2015Fundação para a Ciência e a Tecnologia (FCT), Portugal SFRH/BPD/110883/2015
6 · The paper itself

Abstract

The discovery of bioactive glasses (BGs) in the late 1960s by Larry Hench et al. was driven by the need for implant materials with an ability to bond to living tissues, which were intended to replace inert metal and plastic implants that were not well tolerated by the body. Among a number of tested compositions, the one that later became designated by the well-known trademark of 45S5 Bioglass

Indexed as

additive manufacturing techniquesalkali-freebioactive glassesbone regenerationscaffolds fabricationtissue engineering

Identifiers

PMID30545136
PMCPMC6316906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.